国家医保局：不会再就Paxlovid举行专门谈判_老虎社区_美港股上老虎

国家医保局：不会再就Paxlovid举行专门谈判

老虎资讯综合2023-01-18

对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和辉瑞就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。

从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

RayLv
·2023-01-18
最后究竟谈到多少钱？
回复
点赞
举报
收起
- tyj001:
  170？一片还是一瓶？
  2023-01-19
  回复
  举报
- RayLv:
  那和市场价相差太多了，如果这样以后都没人研究新药了，那他们给的最低价钱呢？
  2023-01-18
  回复
  举报
- alex1984回复RayLv:
  这么便宜，是我们提出来的[无语]
  2023-01-18
  回复
  举报
查看更多 2 条评论
兵姐姐
·2023-01-18
[微笑] [微笑]
回复
点赞
举报
StephZhang
·2023-01-18
之前少做点核酸就有钱买了
回复
11
举报
gdudhfjjfjzh
·2023-01-18
本来再谈也不会有结果啊，再谈也没意义，都要国产了，挣专利费就行。不可能打破全球统一价格的
回复
2
举报
天天呵呵呵
·2023-01-18
能正常价格买到就行了。为什么要一定入医保呢？之前药贩子都卖到12000了。再拖一年，需要用药的人估计都不在了
回复
12
举报
收起
- 虎牙熊猫_:
  h
  2023-01-18
  回复
  举报
- leoguml:
  o
  2023-01-18
  回复
  举报
Robin8888
·2023-01-18
说好的人民的生命至上呢[微笑]
回复
12
举报
喜欢大金毛的哈士奇
·2023-01-18
支持
回复
点赞
举报
特情局川建国
·2023-01-18
呵呵😄
回复
点赞
举报
johnnienew
·2023-01-18
挺好
回复
点赞
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1136276202?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/0bbfa2e2ee47d4ea002fee728d45d7d2","is_english":false,"pubTime":"2023-01-18 18:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1136276202","market":"us","top_or_hot":-1,"title":"国家医保局：不会再就Paxlovid举行专门谈判","media":"老虎资讯综合","content":"<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>国家医保局：不会再就Paxlovid举行专门谈判</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n国家医保局：不会再就Paxlovid举行专门谈判\n</h2>\n\n<h4 class=\"meta\">\n\n2023-01-18 18:39 北京时间&nbsp;&nbsp;&nbsp;<strong>老虎资讯综合</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和辉瑞就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"","article_id":"1136276202","we_media_id":"102","thumbnails":["https://static.tigerbbs.com/0bbfa2e2ee47d4ea002fee728d45d7d2"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1136276202","pubTimestamp":1674038363,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"老虎资讯综合","introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"此前谈判中给出了很大诚意。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"PFE":"辉瑞"},"translate_title":"National Healthcare Security Administration: No more special negotiations on Paxlovid","themeId":"","isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/3da0bce33b489b090d7ac0bb434a6342","symbols_score_info":{"PFE":0.9},"content_text":"对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和辉瑞就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":626856285,"gmtCreate":1674039768647,"gmtModify":1674039851206,"author":{"id":"3521852921707628","authorId":"3521852921707628","name":"RayLv","avatar":"https://static.tigerbbs.com/a246b655b4290d839f9a314fada56f28","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3521852921707628","authorIdStr":"3521852921707628"},"htmlText":"最后究竟谈到多少钱？","listText":"最后究竟谈到多少钱？","text":"最后究竟谈到多少钱？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/626856285","repostId":1136276202,"repostType":4,"repost":{"id":"1136276202","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1674038363,"share":"https://www.laohu8.com/m/news/1136276202?lang=&edition=full","pubTime":"2023-01-18 18:39","market":"us","language":"zh","title":"国家医保局：不会再就Paxlovid举行专门谈判","url":"https://stock-news.laohu8.com/highlight/detail?id=1136276202","media":"老虎资讯综合","summary":"此前谈判中给出了很大诚意。","content":"<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>国家医保局：不会再就Paxlovid举行专门谈判</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n国家医保局：不会再就Paxlovid举行专门谈判\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2023-01-18 18:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/0bbfa2e2ee47d4ea002fee728d45d7d2","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136276202","content_text":"对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和辉瑞就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7839087,"gmtCreate":1674085344646,"gmtModify":1674085357931,"authorId":3558899917750477,"author":{"id":3558899917750477,"idStr":"3558899917750477","authorId":3558899917750477,"name":"tyj001","avatar":"https://static.tigerbbs.com/5f4ce378cde370f75962f88f0dc0f214","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":626856285,"type":1,"supId":7838700,"prevId":0,"content":"170？一片还是一瓶？","text":"170？一片还是一瓶？","html":"170？一片还是一瓶？"},{"id":7838732,"gmtCreate":1674044103745,"gmtModify":1674047390234,"authorId":3521852921707628,"author":{"id":3521852921707628,"idStr":"3521852921707628","authorId":3521852921707628,"name":"RayLv","avatar":"https://static.tigerbbs.com/a246b655b4290d839f9a314fada56f28","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":626856285,"type":1,"supId":7838700,"prevId":0,"content":"那和市场价相差太多了，如果这样以后都没人研究新药了，那他们给的最低价钱呢？","text":"那和市场价相差太多了，如果这样以后都没人研究新药了，那他们给的最低价钱呢？","html":"那和市场价相差太多了，如果这样以后都没人研究新药了，那他们给的最低价钱呢？"},{"id":7838729,"gmtCreate":1674044000578,"gmtModify":1674044013732,"authorId":3513027564673245,"author":{"id":3513027564673245,"idStr":"3513027564673245","authorId":3513027564673245,"name":"alex1984","avatar":"https://static.tigerbbs.com/f0800db53737bf23fc53962623527479","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3521852921707628,"repliedAuthor":{"id":3521852921707628,"idStr":"3521852921707628","authorId":3521852921707628,"name":"RayLv","avatar":"https://static.tigerbbs.com/a246b655b4290d839f9a314fada56f28","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":626856285,"type":1,"supId":7838700,"prevId":7838711,"content":"这么便宜，是我们提出来的[无语]","text":"这么便宜，是我们提出来的[无语]","html":"这么便宜，是我们提出来的[无语]"},{"id":7838711,"gmtCreate":1674040984832,"gmtModify":1674041561092,"authorId":3521852921707628,"author":{"id":3521852921707628,"idStr":"3521852921707628","authorId":3521852921707628,"name":"RayLv","avatar":"https://static.tigerbbs.com/a246b655b4290d839f9a314fada56f28","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":626856285,"type":1,"supId":7838700,"prevId":0,"content":"这么便宜都谈崩！？西方政府都要花大几百美元","text":"这么便宜都谈崩！？西方政府都要花大几百美元","html":"这么便宜都谈崩！？西方政府都要花大几百美元"},{"id":7838700,"gmtCreate":1674040051236,"gmtModify":1674040091239,"authorId":3513027564673245,"author":{"id":3513027564673245,"idStr":"3513027564673245","authorId":3513027564673245,"name":"alex1984","avatar":"https://static.tigerbbs.com/f0800db53737bf23fc53962623527479","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":626856285,"type":1,"supId":0,"prevId":0,"content":"低于170人民币","text":"低于170人民币","html":"低于170人民币"}],"langContent":"CN"},{"id":626858751,"gmtCreate":1674039210373,"gmtModify":1674039212249,"author":{"id":"3547082032543595","authorId":"3547082032543595","name":"兵姐姐","avatar":"https://static.tigerbbs.com/f3142a4bd5765bdffcbf8d9271bf8788","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3547082032543595","authorIdStr":"3547082032543595"},"htmlText":"[微笑]&nbsp;[微笑]&nbsp;","listText":"[微笑]&nbsp;[微笑]&nbsp;","text":"[微笑] [微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/626858751","repostId":1136276202,"repostType":2,"repost":{"id":"1136276202","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1674038363,"share":"https://www.laohu8.com/m/news/1136276202?lang=&edition=full","pubTime":"2023-01-18 18:39","market":"us","language":"zh","title":"国家医保局：不会再就Paxlovid举行专门谈判","url":"https://stock-news.laohu8.com/highlight/detail?id=1136276202","media":"老虎资讯综合","summary":"此前谈判中给出了很大诚意。","content":"<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>国家医保局：不会再就Paxlovid举行专门谈判</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n国家医保局：不会再就Paxlovid举行专门谈判\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2023-01-18 18:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/0bbfa2e2ee47d4ea002fee728d45d7d2","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136276202","content_text":"对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和辉瑞就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":626858588,"gmtCreate":1674039119544,"gmtModify":1674040021122,"author":{"id":"3540243186737690","authorId":"3540243186737690","name":"StephZhang","avatar":"https://static.tigerbbs.com/b013ad0bc96fbd7054e160686835d617","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3540243186737690","authorIdStr":"3540243186737690"},"htmlText":"之前少做点核酸就有钱买了","listText":"之前少做点核酸就有钱买了","text":"之前少做点核酸就有钱买了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/626858588","repostId":1136276202,"repostType":2,"repost":{"id":"1136276202","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1674038363,"share":"https://www.laohu8.com/m/news/1136276202?lang=&edition=full","pubTime":"2023-01-18 18:39","market":"us","language":"zh","title":"国家医保局：不会再就Paxlovid举行专门谈判","url":"https://stock-news.laohu8.com/highlight/detail?id=1136276202","media":"老虎资讯综合","summary":"此前谈判中给出了很大诚意。","content":"<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>国家医保局：不会再就Paxlovid举行专门谈判</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n国家医保局：不会再就Paxlovid举行专门谈判\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2023-01-18 18:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/0bbfa2e2ee47d4ea002fee728d45d7d2","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136276202","content_text":"对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和辉瑞就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":626858803,"gmtCreate":1674038985002,"gmtModify":1674038987210,"author":{"id":"3493041815189173","authorId":"3493041815189173","name":"gdudhfjjfjzh","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3493041815189173","authorIdStr":"3493041815189173"},"htmlText":"本来再谈也不会有结果啊，再谈也没意义，都要国产了，挣专利费就行。不可能打破全球统一价格的","listText":"本来再谈也不会有结果啊，再谈也没意义，都要国产了，挣专利费就行。不可能打破全球统一价格的","text":"本来再谈也不会有结果啊，再谈也没意义，都要国产了，挣专利费就行。不可能打破全球统一价格的","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/626858803","repostId":1136276202,"repostType":2,"repost":{"id":"1136276202","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1674038363,"share":"https://www.laohu8.com/m/news/1136276202?lang=&edition=full","pubTime":"2023-01-18 18:39","market":"us","language":"zh","title":"国家医保局：不会再就Paxlovid举行专门谈判","url":"https://stock-news.laohu8.com/highlight/detail?id=1136276202","media":"老虎资讯综合","summary":"此前谈判中给出了很大诚意。","content":"<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>国家医保局：不会再就Paxlovid举行专门谈判</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n国家医保局：不会再就Paxlovid举行专门谈判\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2023-01-18 18:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/0bbfa2e2ee47d4ea002fee728d45d7d2","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136276202","content_text":"对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和辉瑞就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":626858038,"gmtCreate":1674038841924,"gmtModify":1674038844478,"author":{"id":"3569047979473586","authorId":"3569047979473586","name":"天天呵呵呵","avatar":"https://static.tigerbbs.com/40f8bae2f7dca5818ed19dadfd2304be","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3569047979473586","authorIdStr":"3569047979473586"},"htmlText":"能正常价格买到就行了。为什么要一定入医保呢？之前药贩子都卖到12000了。再拖一年，需要用药的人估计都不在了","listText":"能正常价格买到就行了。为什么要一定入医保呢？之前药贩子都卖到12000了。再拖一年，需要用药的人估计都不在了","text":"能正常价格买到就行了。为什么要一定入医保呢？之前药贩子都卖到12000了。再拖一年，需要用药的人估计都不在了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/626858038","repostId":1136276202,"repostType":2,"repost":{"id":"1136276202","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1674038363,"share":"https://www.laohu8.com/m/news/1136276202?lang=&edition=full","pubTime":"2023-01-18 18:39","market":"us","language":"zh","title":"国家医保局：不会再就Paxlovid举行专门谈判","url":"https://stock-news.laohu8.com/highlight/detail?id=1136276202","media":"老虎资讯综合","summary":"此前谈判中给出了很大诚意。","content":"<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>国家医保局：不会再就Paxlovid举行专门谈判</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n国家医保局：不会再就Paxlovid举行专门谈判\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2023-01-18 18:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/0bbfa2e2ee47d4ea002fee728d45d7d2","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136276202","content_text":"对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和辉瑞就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7838703,"gmtCreate":1674040431602,"gmtModify":1674040444769,"authorId":8797871629438,"author":{"id":8797871629438,"idStr":"8797871629438","authorId":8797871629438,"name":"虎牙熊猫_","avatar":"https://static.tigerbbs.com/371a9aac15a91b50a4e6d9fd016f0e8f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":626858038,"type":1,"supId":0,"prevId":0,"content":"h","text":"h","html":"h"},{"id":7838696,"gmtCreate":1674039571358,"gmtModify":1674039584430,"authorId":3553912822765810,"author":{"id":3553912822765810,"idStr":"3553912822765810","authorId":3553912822765810,"name":"leoguml","avatar":"https://static.tigerbbs.com/65e096d3c71dea09885340989c2c5f80","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":626858038,"type":1,"supId":0,"prevId":0,"content":"o","text":"o","html":"o"}],"langContent":"CN"},{"id":626851401,"gmtCreate":1674038832703,"gmtModify":1674040008704,"author":{"id":"3570784055116477","authorId":"3570784055116477","name":"Robin8888","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3570784055116477","authorIdStr":"3570784055116477"},"htmlText":"说好的人民的生命至上呢[微笑]&nbsp;","listText":"说好的人民的生命至上呢[微笑]&nbsp;","text":"说好的人民的生命至上呢[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/626851401","repostId":1136276202,"repostType":2,"repost":{"id":"1136276202","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1674038363,"share":"https://www.laohu8.com/m/news/1136276202?lang=&edition=full","pubTime":"2023-01-18 18:39","market":"us","language":"zh","title":"国家医保局：不会再就Paxlovid举行专门谈判","url":"https://stock-news.laohu8.com/highlight/detail?id=1136276202","media":"老虎资讯综合","summary":"此前谈判中给出了很大诚意。","content":"<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>国家医保局：不会再就Paxlovid举行专门谈判</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n国家医保局：不会再就Paxlovid举行专门谈判\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2023-01-18 18:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/0bbfa2e2ee47d4ea002fee728d45d7d2","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136276202","content_text":"对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和辉瑞就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":626851178,"gmtCreate":1674038784094,"gmtModify":1674038785714,"author":{"id":"3488795690299047","authorId":"3488795690299047","name":"喜欢大金毛的哈士奇","avatar":"https://static.tigerbbs.com/395ab5be844614d36ce9b2c86ac56b34","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":9,"crmLevelSwitch":0,"idStr":"3488795690299047","authorIdStr":"3488795690299047"},"htmlText":"支持","listText":"支持","text":"支持","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/626851178","repostId":1136276202,"repostType":2,"repost":{"id":"1136276202","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1674038363,"share":"https://www.laohu8.com/m/news/1136276202?lang=&edition=full","pubTime":"2023-01-18 18:39","market":"us","language":"zh","title":"国家医保局：不会再就Paxlovid举行专门谈判","url":"https://stock-news.laohu8.com/highlight/detail?id=1136276202","media":"老虎资讯综合","summary":"此前谈判中给出了很大诚意。","content":"<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>国家医保局：不会再就Paxlovid举行专门谈判</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n国家医保局：不会再就Paxlovid举行专门谈判\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2023-01-18 18:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/0bbfa2e2ee47d4ea002fee728d45d7d2","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136276202","content_text":"对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和辉瑞就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":626851329,"gmtCreate":1674038779461,"gmtModify":1674040008647,"author":{"id":"3573215923585820","authorId":"3573215923585820","name":"特情局川建国","avatar":"https://static.tigerbbs.com/8531fed931d7d6c6d80072e5889dc257","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3573215923585820","authorIdStr":"3573215923585820"},"htmlText":"呵呵😄","listText":"呵呵😄","text":"呵呵😄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/626851329","repostId":1136276202,"repostType":2,"repost":{"id":"1136276202","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1674038363,"share":"https://www.laohu8.com/m/news/1136276202?lang=&edition=full","pubTime":"2023-01-18 18:39","market":"us","language":"zh","title":"国家医保局：不会再就Paxlovid举行专门谈判","url":"https://stock-news.laohu8.com/highlight/detail?id=1136276202","media":"老虎资讯综合","summary":"此前谈判中给出了很大诚意。","content":"<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>国家医保局：不会再就Paxlovid举行专门谈判</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n国家医保局：不会再就Paxlovid举行专门谈判\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2023-01-18 18:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/0bbfa2e2ee47d4ea002fee728d45d7d2","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136276202","content_text":"对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和辉瑞就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":626851963,"gmtCreate":1674038770752,"gmtModify":1674040008651,"author":{"id":"53978154754678","authorId":"53978154754678","name":"johnnienew","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"53978154754678","authorIdStr":"53978154754678"},"htmlText":"挺好","listText":"挺好","text":"挺好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/626851963","repostId":1136276202,"repostType":2,"repost":{"id":"1136276202","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1674038363,"share":"https://www.laohu8.com/m/news/1136276202?lang=&edition=full","pubTime":"2023-01-18 18:39","market":"us","language":"zh","title":"国家医保局：不会再就Paxlovid举行专门谈判","url":"https://stock-news.laohu8.com/highlight/detail?id=1136276202","media":"老虎资讯综合","summary":"此前谈判中给出了很大诚意。","content":"<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>国家医保局：不会再就Paxlovid举行专门谈判</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n国家医保局：不会再就Paxlovid举行专门谈判\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2023-01-18 18:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。</p><p>从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/0bbfa2e2ee47d4ea002fee728d45d7d2","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136276202","content_text":"对于未能通过谈判纳入医保目录的Paxlovid，国家医保局对此回应，不会再和辉瑞就Paxlovid举行专门的谈判。正常情况下，医保目录谈判一年只举行一次。从相关人士处了解到，国家医保局在与辉瑞谈判中给出了“很大的诚意”，但由于双方存在较大的差异而没有谈判成功。医保部门的考虑是“按照说明书，大部分患者都可以使用Paxlovid，我国人口基数大，用药量会非常庞大，医保部门必须考虑资金的承受力和社会承受力。” (一财)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":7,"commentSize":9,"repostSize":0,"favoriteSize":2,"likeStatus":false,"favoriteStatus":false}}